![]()
CATER Mask
Decisions
Extending the Life of Surgical and N95 Masks
Anti-microbials can Eliminate Cleaning and
Damage to Masks
Nexera Guardian FFP 2 Mask Lasts Fourteen Days
and Costs $10 Dollars
The Pandemic Could be Over in Weeks with High
Efficiency Masks
____________________________________________________________________________
Extending the Life of Surgical and N95 Masks
The masks used by the public as compared to
medical workers differ in a number of ways. The
risk in medical settings is greater because of
·
higher viral loads (number of individuals
with COVID)
·
vulnerable populations ( e.g. cancer patients)
For the medical worker dealing with COVID cases
the chance of being in the vicinity of a COVID
emitter is nearly 100%. In the worst case public
scenario one out of every hundred individuals is
a transmitter and typically it is only 1 in
1000.
Protection is all about reducing the odds. If
a person because of occupation is 1000
times more likely to need the protection than
another he should not consider compromising mask
efficiency by extended wear.
A person in a poor country whose alternative is
a cloth mask which
has an FFE of 10% would be better off
with a mask which is initially very efficient
but over time deteriorates. It is still a better
choice until it reaches an FEE of 10%.
Deterioration can involve fit and filter media
efficiency. Another factor is transmission of
virus from the mask surface. Masks with
anti-microbial media do not have to be cleaned
as frequently.
This may greatly extend the life.
Nexera recommends its FFP 2 mask for use of up
to 14 days.
It costs approximately $10. So the cost
per day of use is 71 cents.
The mask is rated FFP 2 with 6% penetration and
less than 8% inward leakage. So the FFE rating
would be 86%. $30 CATER masks have been tested
at an FFE of 90%. The recommended life of these
masks is up to 90 days. A
$2 upgraded surgical mask with a brace
might have an FFE above 85%. The brace has
potentially 1 year of life. The surgical mask
might have a life of weeks.
Various mask types are likely to deteriorate at
different rates.
For rough comparison purposes we used a
high deterioration rate (A) and a slower one
(B).
A brace could cost $15 or could be a DIY
version.
With 4 per year x $2 plus 15 for the
brace the total is $22 per year. For a country
such as India this would be a $22 billion/yr
expense.
The wealthiest citizens will want CATER masks
and purchase at least four per year at $30 each.
A middle class group could spend $50/yr
each while 3.2 billion people would average only
$25 each.
This results in 2021 market of $296 billion.
This investment would insure the end of the
pandemic and would be a small price to pay
considering the lives saved and economic
benefits.
Anti-microbials in high risk settings can be
justified just on the risk reduction associated
with viruses transmitted from the mask surface.
In low risk settings these anti microbials can
be justified based on reduced mask cleaning and
resultant deterioration.
Asten Johnson provides Foss media. Sciessent
provides antimicrobials to be used with the
media.
Nexera and
Haynes are supplying masks using the
media Thorough testing has shown the silver-copper antimicrobial compounds to be nontoxic and effective, making the agents perfectly suited for antimicrobial respirator masks. These same antimicrobial agents are National Science Foundation (NSF) and U.S. Federal Drug Administration (FDA) listed and U.S. Environmental Protection Agency (EPA) registered. They are also listed with the Cosmetic, Toiletry, and Fragrance Association as a cosmetic preservative and have the standard approval in Europe under the Biocidal Products Directive.
The cornerstone of the technology is silver
(Ag), a naturally occurring, safe, and effective
antimicrobial agent in its ionic form. The
delivery system is a zeolite carrier that allows
a controlled and effective release of the silver
ions, on demand, thus killing and inhibiting the
growth of bacteria, viruses, mold, and fungus
over long periods of time. This stable ion
exchange process is non-reactive and allows the
compound to be used in virtually every
imaginable manufacturing process.
Sciessent says that unlike the premeditated work
with Nexera to develop a mask following the SARS
outbreak nearly two decades ago, work with
Hanesbrands required that the team leverage
existing knowledge and experience to quickly
fill-in various information gaps. Instead of
developing a product from the ground up,
Hanesbrands was repurposing its knitted cotton
fabrics treated with Agion Antimicrobial to
develop its masks.
With the next generation microbe-fighting
technology, the SpectraShield™ GUARDIAN is the
first ever REUSABLE antimicrobial protected FFP2
respirator mask. It is creatively engineered to
be reused for up to 14 days. Its patented, safe,
natural, and effective Fosshield® antimicrobial
technology penetrates the microbe’s cell wall,
attacks its metabolism and disrupts
reproduction. Approved under E.U. classification
EN149:2001 + A1:2009 Features and Benefits:
• Regulatory: EU FFP2 and Reusability certified
• Superior Performance: – Proven highly
effective against the following viruses: -
Influenza A (Swine Flu or H1N1) - Avian Flu
(H5N1) - Rhinovirus - Adenovirus - Coronavirus –
Begins microbe prevention immediately and
eliminates 99.99% of the following tested
bacteria after one hour of contact with the
surface of the respirator: - Methycillin
Resistant Staphylococcus Aureus (MRSA) -
Streptococcus Pyogenese - Haemophilus Influenzae
- Legionella Pnuemophila
• Protection: – Shields from blood, other bodily
fluids, and a wide spectrum of airborne
respiratory threats – Meets CDC and WHO
guidelines for tuberculosis and other infectious
disease exposure control – Filters out viruses,
fungi, bacteria, pollen and other airborne
irritants; including non-oil containing fumes,
mists and dust – Hypoallergenic
•
Design: – Reusable wear for up to 14 days –
Unique construction naturally contours to facial
features for a guaranteed proper fit – PVC and
latex-free – Uses same safe and effective
Fosshield® antimicrobial technology incorporated
in Nexera’s FDA 510(k) cleared surgical
respirator mask
Devabhaktuni Srikrishna
will be a presenter in the webinar on the 2lst
where we will be
discussing the impact of more
efficient masks. He has used the Wells-Riley
model on infection risk to show the impact of
higher efficiency masks.
His findings are consistent with what has
been reported in the Alert. Here is a summary of
his new paper.
Abstract
Background Recently
the US CDC acknowledged that the COVID-19 crisis
is facilitated at least in part by aerosolized
virus exhaled by symptomatic, asymptomatic, or
pre-symptomatic infected individuals. Disposable
N95 masks remain in short supply due to their
use in healthcare settings during the
Coronavirus pandemic, whereas NIOSH-approved
elastomeric N95 (eN95) masks remain immediately
available for use by essential workers and the
general public. New reusable N95 mask options
with symmetric filtration efficiency can be
anticipated to be NIOSH approved in the coming
months, today’s eN95 masks have asymmetric
filtration efficiency upon inhalation (95%) and
exhalation (well under 95%) but are available
now during the Fall and Winter when Coronavirus
cases are expected to peak.
Methods Based
on the Wells-Riley model of infection risk, we
examine how the rate of transmission of the
virus from one infected person in a closed,
congested room with poor ventilation to several
other susceptible individuals is impacted by the
filtration efficiency of the masks they are
wearing. Three scenarios are modeled – a room (6
people, 12’ × 20’ × 10’), a bar (18 people, 20’
× 40’ × 10’), and a classroom (26 people, 20’ ×
30’ × 10’) with one infectious individual and
remaining susceptibles.
By dynamically estimating the accumulation of
virus in aerosols exhaled by the infected person
in these congested spaces for four hours using a
“box model,” we compare the transmission risk
(probability) when susceptible people based on a
realistic hypothesis of face mask protection
during inhaling and exhaling e.g. using cloth
masks or N95 respirators.
Results Across
all three scenarios, cloth masks modeled with
30% symmetric filtration efficiency alone were
insufficient to stop the spread (18% to 40%
infection risk), whereas eN95 masks (modeled as
95% filtration efficiency on inhalation, 30% on
exhalation) reduced the infection risk to 1.5%
to 3.6%. Symmetric filtration of 80% reduces the
risk to 1.7% to 4.1% and symmetric filtration of
95% would further reduce the risk to 0.11% to
0.26%.
Conclusion This
modeling of mask filtration efficiency suggests
that the pandemic could be readily controlled
within several weeks if (in conjunction with
sensible hygiene) a sufficiently large majority
of people wear asymmetric but higher-filtration
masks (e.g. eN95) that also block aerosols
whenever exposed to anyone else outside their
household in order to completely stop
inter-household spread.
https://www.medrxiv.org/content/10.1101/2020.11.10.20227710v1
|